Marco Losa

2.1k total citations
20 papers, 812 citations indexed

About

Marco Losa is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Marco Losa has authored 20 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Marco Losa's work include Prion Diseases and Protein Misfolding (5 papers), Eosinophilic Esophagitis (2 papers) and Trace Elements in Health (2 papers). Marco Losa is often cited by papers focused on Prion Diseases and Protein Misfolding (5 papers), Eosinophilic Esophagitis (2 papers) and Trace Elements in Health (2 papers). Marco Losa collaborates with scholars based in Switzerland, Italy and United States. Marco Losa's co-authors include Marco A. Pierotti, Federica Perrone, Marta Orsenigo, Lucio Bertario, Enrico Leo, S. Pilotti, Arpine Gevorgyan, Emilio Bajetta, Catherine Riva and Andrea Lampis and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The EMBO Journal.

In The Last Decade

Marco Losa

19 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Losa Switzerland 11 456 334 242 154 146 20 812
Rong-Zhen Luo China 20 274 0.6× 737 2.2× 230 1.0× 346 2.2× 65 0.4× 40 1.2k
Hirokazu Amaya Japan 12 369 0.8× 581 1.7× 242 1.0× 316 2.1× 79 0.5× 20 913
Fernando Pardal Portugal 16 236 0.5× 404 1.2× 123 0.5× 211 1.4× 136 0.9× 26 829
Toshifumi Kameyama Japan 14 247 0.5× 328 1.0× 165 0.7× 129 0.8× 59 0.4× 27 688
Keisuke Matsusaki Japan 20 385 0.8× 566 1.7× 213 0.9× 259 1.7× 131 0.9× 43 1.1k
Emily Chan United States 14 259 0.6× 270 0.8× 282 1.2× 145 0.9× 114 0.8× 54 723
Hideyuki Abe Japan 20 416 0.9× 294 0.9× 351 1.5× 213 1.4× 141 1.0× 63 907
Jotaro Hata Japan 9 416 0.9× 283 0.8× 209 0.9× 91 0.6× 84 0.6× 14 773
Lorena Bottarelli Italy 18 661 1.4× 454 1.4× 367 1.5× 190 1.2× 238 1.6× 51 1.1k
Jan Åkervall Sweden 20 418 0.9× 564 1.7× 164 0.7× 224 1.5× 80 0.5× 44 1.1k

Countries citing papers authored by Marco Losa

Since Specialization
Citations

This map shows the geographic impact of Marco Losa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Losa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Losa more than expected).

Fields of papers citing papers by Marco Losa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Losa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Losa. The network helps show where Marco Losa may publish in the future.

Co-authorship network of co-authors of Marco Losa

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Losa. A scholar is included among the top collaborators of Marco Losa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Losa. Marco Losa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Thackray, Alana M., Yingjun Liu, Marián Hruška-Plocháň, et al.. (2022). An arrayed genome‐wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate‐limiting for prion propagation. The EMBO Journal. 41(23). e112338–e112338. 5 indexed citations
4.
Malinovska, Liliana, Marco Losa, Mattheus H. E. Wildschut, et al.. (2022). Calreticulin mutations affect its chaperone function and perturb the glycoproteome. Cell Reports. 41(8). 111689–111689. 11 indexed citations
5.
Lakkaraju, Asvin KK, et al.. (2021). Loss of PIKfyve drives the spongiform degeneration in prion diseases. EMBO Molecular Medicine. 13(9). e14714–e14714. 25 indexed citations
6.
Losa, Marco, et al.. (2021). Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non‐erosive reflux disease. Neurogastroenterology & Motility. 33(9). e14177–e14177. 28 indexed citations
7.
Losa, Marco, et al.. (2021). Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Therapeutic Advances in Gastroenterology. 14. 1088184994–1088184994. 22 indexed citations
8.
Frontzek, Karl, Marco Losa, Georg Meisl, et al.. (2020). Autoantibodies against the prion protein in individuals with PRNP mutations. Neurology. 95(14). e2028–e2037. 10 indexed citations
9.
Senatore, Assunta, Karl Frontzek, Marc Emmenegger, et al.. (2020). Protective anti‐prion antibodies in human immunoglobulin repertoires. EMBO Molecular Medicine. 12(9). e12739–e12739. 14 indexed citations
10.
Losa, Marco, et al.. (2019). An Infratentorial Tumor in a 44‐Year‐Old Female Patient. Brain Pathology. 29(1). 145–146.
11.
Civenni, Gianluca, Martina Marchetti‐Deschmann, Shusil K. Pandit, et al.. (2017). Abstract 2900: Sigma-1 receptor control tumorigenic and stem cell-like phenotype in human cancers. Cancer Research. 77(13_Supplement). 2900–2900. 1 indexed citations
12.
Albino, Domenico, Gianluca Civenni, Jessica Merulla, et al.. (2016). MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression. Journal of Clinical Investigation. 126(12). 4585–4602. 74 indexed citations
13.
Revandkar, Ajinkya, Alberto Toso, Abdullah Alajati, et al.. (2016). Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nature Communications. 7(1). 13719–13719. 41 indexed citations
14.
Neidert, Marian C., Marco Losa, Luca Regli, & Johannes Sarnthein. (2015). Elevated serum creatine kinase after neurosurgeries in lateral position with intraoperative neurophysiological monitoring is associated with OP duration, BMI and age. Clinical Neurophysiology. 126(10). 2026–2032. 3 indexed citations
15.
Perrone, Federica, Andrea Lampis, Marta Orsenigo, et al.. (2008). PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Annals of Oncology. 20(1). 84–90. 337 indexed citations
16.
Miselli, Francesca, Tiziana Negri, Alessandro Gronchi, et al.. (2008). Is Autophagy Rather Than Apoptosis the Regression Driver in Imatinib-Treated Gastrointestinal Stromal Tumors?. Translational Oncology. 1(4). 177–186. 24 indexed citations
17.
Mezzanzanica, Delia, Marina Fabbi, Marina Bagnoli, et al.. (2008). Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients. Clinical Cancer Research. 14(6). 1726–1733. 81 indexed citations
18.
Pricl, Sabrina, Elena Tamborini, Tiziana Negri, et al.. (2007). A clinical/modeling investigation of the activity of PKC412 against an imatinib-resistant gastrointestinal stromal tumor (GIST) Carrying a D842V Mutation in PDGFRA. 67. 3266–3266. 1 indexed citations
19.
Perrone, Federica, Simona Suardi, Elisa Pastore, et al.. (2006). Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma. Clinical Cancer Research. 12(22). 6643–6651. 132 indexed citations
20.
Schopohl, Jochen, G. Mehltretter, Marco Losa, et al.. (1989). Changes of anterior pituitary function in male patients with hypothalamic hypogonadism during pulsatile therapy with GnRH and testosterone replacement. European Journal of Endocrinology. 120(3_Suppl). S49–S50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026